Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × Amifostine × Clear all

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

NCT00098683 2014-02-13

Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

Phase 2 Completed

10 enrolled

Classical hematologyMyeloid

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases

NCT00003827 2013-12-04

Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome

Phase 2 Unknown

25 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

Clinical Trials

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes

Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome